April 03, 2007; 68 (14) Articles
Intravenous immunoglobulin therapy for Miller Fisher syndrome
Masahiro Mori, Satoshi Kuwabara, Toshio Fukutake, Takamichi Hattori
First published April 2, 2007, DOI: https://doi.org/10.1212/01.wnl.0000258673.31824.61
Masahiro Mori
Satoshi Kuwabara
Toshio Fukutake
Intravenous immunoglobulin therapy for Miller Fisher syndrome
Masahiro Mori, Satoshi Kuwabara, Toshio Fukutake, Takamichi Hattori
Neurology Apr 2007, 68 (14) 1144-1146; DOI: 10.1212/01.wnl.0000258673.31824.61
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 68 no. 14 1144-1146
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published April 2, 2007.
Copyright & Usage:
© 2007
Author Disclosures
- Masahiro Mori, MD,
- Satoshi Kuwabara, MD,
- Toshio Fukutake, MD and
- Takamichi Hattori, MD
- Masahiro Mori, MD,
- Satoshi Kuwabara, MD,
- Toshio Fukutake, MD and
- Takamichi Hattori, MD
- From the Department of Neurology, Graduate School of Medicine, Chiba University, Inohana, Chuo-ku, Chiba, Japan (M.M., S.K., T.H.); and Department of Neurology, Kameda Medical Center, Higashi-cho, Kamogawa-shi, Chiba, Japan (T.F.).
- Address correspondence and reprint requests to Dr. Masahiro Mori, Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670 Japan; e-mail: morim{at}faculty.chiba-u.jp
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.